Antimetastatic effect of desmopressin in a mouse mammary tumor model

Breast Cancer Research and Treatment

Volumn 57, Issue 3, 1999, Pages 271-275

  Alonso, Daniel F ^b,c   Skilton, Guillermo ^c   Farïas, Eduardo F ^a   Bal De Kier Joffé, Elisa ^a   Gomez, Daniel E ^c  

^a Instituto de Oncologia Angel H Roffo   (Argentina)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^c NONE

Author keywords

Breast cancer; Desmopressin; Metastasis; Tumor cell aggregation

Indexed keywords

ANTIMETASTATIC AGENT; DESMOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL AGGREGATION; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; FIBRINOLYSIS; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PLASMA; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; CELL AGGREGATION; DEAMINO ARGININE VASOPRESSIN; FEMALE; HEMOSTATICS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C;

EID: 0032784817     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006291607871     Document Type: Article

References (23)

1. 1. Fidler IJ: Cancer metastasis. Br Med Bull 47: 157-177, 1991
2. 2. Constantini V, Zacharski LR: The role of fibrin in tumor metastasis. Cancer Metastasis Rev 11: 283-290, 1992
3. 3. Weiss L, Orr FW, Honn KV: Interactions of cancer cells with the microvasculature during metastasis. FASEB J 2: 12-21, 1988
4. 4. Alonso DF, Skilton G, Farina HG, De Lorenzo MS, Gomez DE: Modulation of growth and urokinase secretion by vasopressin and closely related nonapeptides in metastatic mouse mammary tumor cells. Int J Oncol 10: 375-379, 1997
5. 5. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993
6. 6. Richardson DW, Robinson AG: Desmopressin. Ann Intern Med 103: 228-239, 1985
7. 7. Alonso DF, Farías EF, Urtreger A, Ladeda V, Vidal MC, Bal de Kier Joffé E: Characterization of F3II, a mammary sarcomatoid carcinoma cell line originated from a mouse adenocarcinoma. J Surg Oncol 62: 288-297, 1996
8. 8. Urtreger A, Ladeda V, Puricelli L, Rivelli A, Vidal MC, Sacerdote de Lustig E, Bal de Kier Joffé E: Modulation of fibronectin expression and proteolytic activity associated with the invasive and metastatic phenotype in two new murine mammary tumor cell lines. Int J Oncol 11: 489-496, 1997
9. 9. Alonso DF, Farías EF, Ladeda V, Davel L, Puricelli P, Bal de Kier Joffé E: Effects of synthetic urokinase inhibitors on local invasion and metastatic dissemination in a murine mammary tumor model. Breast Cancer Res Treat 40: 209-233, 1996
10. 10. Inohara H, Akahami S, Koths K, Raz A: Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res 56: 4530-4534, 1996
11. 11. Esumi N, Fan D, Fidler IJ: Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudine, a highly specific thrombin inhibitor. Cancer Res 51: 4549-4556, 1991
12. 12. Gunji Y, Gorelik E: Role of fibrin coagulation in protection of murine tumor cells from destruction by cytotoxic cells. Cancer Res 48: 5216-5221, 1998
13. 13. Alonso DF, Bertolesi GE, Farías EF, Gomez DE, Bal de Kier Joffé E: Inhibition of fibrinolysis by a synthetic urokinase inhibitor enhances lung colonization of metastatic murine mammary tumor cells. Oncol Rep 3: 1055-1058, 1996
14. 14. Gader AMA, Da Costa J, Cash JD: A new vasopressin analogue and fibrinolysis. Lancet ii: 1417-1418, 1973
15. 15. Mannucci PM, Aberg M, Nilsson IM, Robertson B: Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol 30: 81-93, 1975
16. 16. Kanwar S, Woodman RC, Poon MC, Murohara T, Lefer AM, Davenpeck KL, Kubes P: Desmopressin induces endothelial P-selectin expression and leukocyte rolling in postcapillary venules. Blood 86: 2760-2766, 1995
17. 17. Wun T, Paglieroni TG, Lachant NA: Desmopressin stimulates the expression of P-selectin on human platelets in vitro. J Lab Clin Med 126: 401-409, 1995
18. 18. Yamada Y, Nakayama M, Nakano H, Mimura N, Yoshida S: Endothelium-dependent vasorelaxation evoked by desmopressin and involvement of nitric oxide in rat aorta. Am J Physiol 264: E203-E207, 1993
19. 19. Hirano S: In vitro and in vivo cytotoxic effects of nitric oxide on metastatic cells. Cancer Lett 115: 57-62, 1997
20. 20. Mannucci PM: Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. Blood 72: 1449-1455, 1988
21. 21. Horrow JC: Desmopressin and antifibrinolytics. Int Anesthesiol Clin 28: 230-236, 1990
22. 22. Lethagen S: Desmopressin (DDAVP) and hemostasis. Ann Hematol 69: 173-180, 1994
23. 23. Brown DC, Purushotham AD, Birnie GD, George WD: Detection of intraoperative tumor cell dissemination in patients with breast cancer using reverse transcription and polymerase chain reaction. Surgery 117: 95-101, 1995